Posts Tagged ‘Biosimilar’

Biosimilar development and bioanalytical comparability analysis using Pfenex Expression Technology® with a cloud-based informatics solution

By: Diane Retallack, Ph.D., Director, Molecular Biology at Pfenex At Pfenex, we are in the business of developing biosimilars. And, as a result, on a daily basis we produce data—lots of it. This data enables the team at Pfenex to rapidly demonstrate analytical similarity between a Pfenex biosimilar candidate and the reference drug product.  The ability…

Read More